About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Nitazoxanide, potent drug to plug the purge caused by rotavirus

by Medindia Content Team on June 26, 2006 at 5:25 PM
Font : A-A+

Nitazoxanide, potent drug to plug the purge caused by rotavirus

Nitazoxanide holds immense promise for kids infected with Rotavirus that triggers severe diarrhea, now infamous for causing half a million deaths amongst youngsters from the deprived countries. Now, this drug has also received the approval from the FDA for its use in combating gastrointestinal infections in children.

A team of Researchers at the Romark Institute for Medical Research in Tampa, Florida, compared the efficacy of nitazoxanide administered twice a day for three days vis a vis a placebo amongst 50 children who were suffering severe diarrhea. The study revealed that nitazoxanide was capable of remedying the illness in about 30 hours with negligible side effects.

Advertisement


Advertisement
<< Antibacterial Products Ensure Food Safety and Health
No Need For Malaria Hospital In Kolkata >>

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Resource
Advertisement
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
Smallpox
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 
Recommended Reading
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use